1. Home
  2. Stocks
  3. Jbchepharm Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • J B Chemicals & Pharmaceuticals

    Large Cap
    ₹1,884.7
    + 21.95 (1.18%)
    • Advice
    • Hold
    27 July, 2024 11:46 BSE: 506943 NSE: JBCHEPHARM ISIN: INE572A01036
    Split

    Start SIP in J B Chemicals & Pharmaceuticals

    Start SIP

    J B Chemicals & Pharmaceuticals Performance

    Day Range

    • Low 1,863
    • High 1,899
    ₹ 1,884

    52 Week Range

    • Low 1,184
    • High 1,940
    ₹ 1,884
    • Open Price1,863
    • Previous Close1,863
    • Volume95123

    J B Chemicals & Pharmaceuticals Share Price

    • Over 1 Month + 9.27%
    • Over 3 Month + 1.05%
    • Over 6 Month + 11.16%
    • Over 1 Year + 53.87%

    J B Chemicals & Pharmaceuticals Key Statistics

    P/E Ratio 52.9
    PEG Ratio 1.5
    Market Cap Cr
    Price to Book Ratio 10
    EPS 35
    Dividend 0.5
    Relative Strength Index 66.39
    Money Flow Index 38.33
    MACD Signal 6.72
    Average True Range 50.91
    J B Chemicals & Pharmaceuticals Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 809800837853699
    Operating Expenses Qtr Cr 614585602618538
    Operating Profit Qtr Cr 195215235235161
    Depreciation Qtr Cr 4033323131
    Interest Qtr Cr 81291112
    Tax Qtr Cr 3748565433
    Net Profit Qtr Cr 12612814514589
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3,3332,893
    Operating Expenses Annual Cr 2,4192,219
    Operating Profit Annual in Cr 879665
    Depreciation Cr 135112
    Interest Annual Cr 4134
    Tax Annual Cr 195138
    Net Profit Annual Cr 543389
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 789629
    Cash from Investing Activity Annual Cr -412-956
    Cash from Financing Annual Activity Cr -374343
    Net Cash Flow Annual Cr 316
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,8862,442
    Fixed Assets Annual Cr 2,0011,877
    Total Non Current Assets Annual Cr 2,1832,072
    Total Current Assets Annual Cr 1,7301,398
    Total Assets Annual Cr 3,9143,470
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 186316
    ROE Annual % 1916
    ROCE Annual % 2519
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2823
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 862845882896762
    Operating Expenses Qtr Cr 664621638664599
    Operating Profit Qtr Cr 198223244232164
    Depreciation Qtr Cr 4134323132
    Interest Qtr Cr 912101214
    Tax Qtr Cr 3850585235
    Net Profit Qtr Cr 12613415114288
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3,5213,159
    Operating Expenses Annual Cr 2,5872,454
    Operating Profit Annual in Cr 897696
    Depreciation Cr 138114
    Interest Annual Cr 4436
    Tax Annual Cr 199145
    Net Profit Annual Cr 553410
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 801626
    Cash from Investing Activity Annual Cr -404-962
    Cash from Financing Annual Activity Cr -385357
    Net Cash Flow Annual Cr 1120
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,9232,480
    Fixed Assets Annual Cr 2,0231,899
    Total Non Current Assets Annual Cr 2,1262,026
    Total Current Assets Annual Cr 1,8681,528
    Total Assets Annual Cr 3,9943,554
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 188321
    ROE Annual % 1917
    ROCE Annual % 2520
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2722
    Invest in J B Chemicals & Pharmaceuticals

    J B Chemicals & Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹1,884.7
    + 21.95 (1.18%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹1,803.68
    • 50 Day
    • ₹1,784.90
    • 100 Day
    • ₹1,745.55
    • 200 Day
    • ₹1,639.93
    • 20 Day
    • ₹1,787.73
    • 50 Day
    • ₹1,785.36
    • 100 Day
    • ₹1,747.48
    • 200 Day
    • ₹1,647.17

    J B Chemicals & Pharmaceuticals Resistance and Support

    PIVOT
    ₹1,882.05
    Resistance
    First Resistance 1,901.35
    Second Resistance 1,918.00
    Third Resistance 1,937.30
    RSI 66.39
    MFI 38.33
    MACD Single Line 6.72
    MACD 20.87
    Support
    First Support 1,865.40
    Second Support 1,846.10
    Third Supoort 1,829.45

    J B Chemicals & Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 98,244 6,567,611 66.85
    Week 115,212 7,239,922 62.84
    1 Month 246,954 10,201,682 41.31
    6 Month 202,048 11,294,505 55.9

    J B Chemicals & Pharmaceuticals Result Highlights

    J B Chemicals & Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    J B Chemicals & Phar is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3298.64 Cr. and Equity Capital is Rs. 15.52 Cr. for the Year ended 31/03/2024. J B Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/1976 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24390MH1976PLC019380 and registration number is 019380.
    Market Cap 29,253
    Sales 3,299
    Shares in Float 7.14
    No of funds 264
    Yield 0.29
    Book Value 10.13
    U/D Vol ratio 1.5
    LTDebt / Equity 1
    Alpha 0.13
    Beta 0.56

    J B Chemicals & Pharmaceuticals Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 53.77%53.78%53.83%53.86%
    Mutual Funds 15.04%15.45%15.66%15.57%
    Insurance Companies 1.93%2.36%2.3%2.45%
    Foreign Portfolio Investors 12.17%11.06%10.35%10.05%
    Financial Institutions/ Banks
    Individual Investors 14.38%14.69%15.16%15.33%
    Others 2.71%2.66%2.7%2.74%

    J B Chemicals & Pharmaceuticals Management

    Name Designation
    Mr. Ranjit Shahani Chairman & Ind.Director
    Mr. Nikhil Chopra WholeTime Director & CEO
    Mr. Prashant Kumar Non Executive Director
    Mr. Gaurav Trehan Non Executive Director
    Mr. Sumit Bose Independent Director
    Ms. Padmini Khare Kaicker Independent Director

    J B Chemicals & Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    J B Chemicals & Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-05-17 Audited Results & Final Dividend
    2024-02-06 Quarterly Results & Interim Dividend
    2023-11-07 Quarterly Results
    2023-08-09 Quarterly Results
    2023-05-24 Audited Results, Dividend & Stock Split
    Date Purpose Remarks
    2024-02-16 INTERIM Rs.5.50 per share(550%)Interim Dividend
    2023-02-18 INTERIM Rs.8.50 per share(425%)Interim Dividend
    2022-02-24 INTERIM Rs.8.50 per share(425%)Interim Dividend
    2021-02-22 INTERIM Rs.8.50 per share(425%)Interim Dividend
    Date Purpose Remarks
    2023-09-18 Split Rs.0.00 split from Rs. 2/- to 1/-.

    J B Chemicals & Pharmaceuticals MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 56,469
    Kotak Emerging Equity Scheme Growth 49,023
    Nippon India Multi Cap Fund - Growth 34,943
    Nippon India Growth Fund - Growth 30,839
    Axis Midcap Fund Growth 30,144

    J B Chemicals & Pharmaceuticals FAQs

    What is Share Price of J B Chemicals & Pharmaceuticals ?

    J B Chemicals & Pharmaceuticals share price is ₹1,884 As on 27 July, 2024 | 11:32

    What is the Market Cap of J B Chemicals & Pharmaceuticals ?

    The Market Cap of J B Chemicals & Pharmaceuticals is ₹29253 Cr As on 27 July, 2024 | 11:32

    What is the P/E ratio of J B Chemicals & Pharmaceuticals ?

    The P/E ratio of J B Chemicals & Pharmaceuticals is 52.9 As on 27 July, 2024 | 11:32

    What is the PB ratio of J B Chemicals & Pharmaceuticals ?

    The PB ratio of J B Chemicals & Pharmaceuticals is 10 As on 27 July, 2024 | 11:32

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.